<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style>
  • Using technology in tumor genomics to develop precision cancer therapeutics

    Investor Relations

SEC Filings

Trovagene is publicly traded on the NASDAQ stock exchange under the symbol TROV.

NASDAQTROV
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventJun 26, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-K/AAmendment to a previously filed 8-KJun 23, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 23, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 22, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 7, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 2, 2017View HTMLDownload DOCDownload PDFDownload XLS
25-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesMay 30, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMay 25, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 23, 2017View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderMay 19, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMay 10, 2017View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionMay 10, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventMay 1, 2017View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveApr 28, 2017View HTMLDownload DOCDownload PDFDownload XLS
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 28, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 26, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 25, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 14, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 10, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 10, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 28, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 27, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 21, 2017View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75

email print
3:34
3:34
Wistia video thumbnail - Susann-Berz Patient Video- Home Page

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?

Cancel
message